nimesulide has been researched along with Constriction, Pathologic in 2 studies
nimesulide: structure
nimesulide : An aromatic ether having phenyl and 2-methylsulfonamido-5-nitrophenyl as the two aryl groups.
Constriction, Pathologic: The condition of an anatomical structure's being constricted beyond normal dimensions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a term pregnancy, nimesulide administration can rapidly cause premature ductal constriction." | 3.74 | Acute premature constriction of the ductus arteriosus after maternal self-medication with nimesulide. ( De Biasio, P; Marasini, M; Prefumo, F; Venturini, PL, 2008) |
| "Although the true incidence of the adverse effect of nimesulide ingestion during pregnancy cannot be deduced, we believe that patients and their clinicians should be alerted to the possibility that clinically significant ductal constriction may follow maternal self-medication with just one or two oral doses of nimesulide, at least if the drug is taken near term." | 3.73 | Severe ductal constriction in the third-trimester fetus following maternal self-medication with nimesulide. ( Marasini, M; Paladini, D; Volpe, P, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Paladini, D | 1 |
| Marasini, M | 2 |
| Volpe, P | 1 |
| Prefumo, F | 1 |
| De Biasio, P | 1 |
| Venturini, PL | 1 |
2 other studies available for nimesulide and Constriction, Pathologic
| Article | Year |
|---|---|
Severe ductal constriction in the third-trimester fetus following maternal self-medication with nimesulide.
Topics: Administration, Oral; Constriction, Pathologic; Cyclooxygenase Inhibitors; Delivery, Obstetric; Duct | 2005 |
Acute premature constriction of the ductus arteriosus after maternal self-medication with nimesulide.
Topics: Acute Disease; Adult; Constriction, Pathologic; Cyclooxygenase 2 Inhibitors; Ductus Arteriosus; Fema | 2008 |